Tampere University ULTRASOUND group
Published February 23, 2011 | Version v1
Book chapter Embargoed

CEUS and sonoporation

Authors/Creators

  • 1. University of Bergen

Description

In this chapter, contrast-enhanced ultrasound (CEUS) and ultrasound contrast agent microbubble adjustments for drug delivery including sonoporation are described. Although hundreds of papers have been published on this subject, we will just briefly touch upon the topic using a physics and engineering approach.

Files

Embargoed

The files will be made publicly available on August 19, 2033.

Additional details

Related works

Is part of
Book: 10.1201/9781482266641 (DOI)

References

  • Krestan C. Ultraschallkontrastmittel: Substanzklassen, Pharmakokinetik, klinische Anwendungen, Sicherheitsaspekte. Radiologe 2005 45:513–519.
  • Postema M, Schmitz G. Bubble dynamics involved in ultrasonic imaging. Expert Rev Mol Diagn 2006 6:493–502.
  • Schutt EG, Klein DH, Mattrey RM, Riess JG. Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals. Angew Chem Int Ed 2003 42:3218–3235.
  • Fisher NG, Christiansen JP, Klibanov A, Taylor RP, Kaul S, Lindner JR. Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement. J Am Coll Cardiol 2002 40:811–819.
  • Becher H, Burns PN. Handbook of Contrast Echocardiography: LV Function and Myocardial Perfusion. Berlin: Springer 2000.
  • Miller AP, Nanda NC. Contrast echocardiography: new agents. Ultrasound Med Biol 2004 30:425–434.
  • Heynemann H, Jenderka KV, Zacharias M, Fornara P. Neue Techniken der Urosonographie. Urologe 2004 43:1362–1370.
  • Droste DW, Kaps M, Navabi DG, Ringelstein EB. Ultrasound contrast enhancing agents in neurosonology: principles, methods, future possibilities. Acta Neurol Scand 2000 102:1–10.
  • Mischi M, Jansen AHM, Kalker AACM, Korsten HHM. Identification of ultrasound contrast agent dilution systems for ejection fraction measurements. IEEE Trans Ultrason Ferroelectr Freq Control 2005 52:410–420.
  • Heppner P, Lindner JR. Contrast ultrasound assessment of angiogenesis by perfusion and molecular imaging. Expert Rev Mol Diagn 2005 5:447–455.
  • Lindner JR. Microbubbles in medical imaging: current applications and future directions. Nature Rev Drug Discov 2004 3:527–532.
  • Albrecht T, Blomley M, Bolondi L, Claudon M, Correas JM, Cosgrove D, Greiner L, J ̈ager K, Jong ND, Leen E, Lencioni R, Lindsell D, Martegani A, Solbiati L, Thorelius L, Tranquart F, Weskott HP, Whittingham T. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med 2004 25:249–256.
  • Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, Calliada F, Correas JM, Darge K, Dietrich C, D'Onofrio M, Evans DH, Filice C, Greiner L, J ̈ager K, Jong N, Leen E, Lencioni R, Lindsell D, Martegani A, Meairs S, Nolsøe C, Piscaglia F, Ricci P, Seidel G, Skjoldbye B, Solbiati L, Thorelius L, Tranquart F, Weskott HP, Whittingham T. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) — update 2008. Ultraschall Med 2008 29:28–44.
  • Faccioli N, Crippa S, Bassi C, D'Onofrio M. Contrast-enhanced ultrasonography of the pancreas. Pancreatology 2009 9:560–566.
  • D ̈orffel Y, Wermke W. Neuroendocrine tumors: characterization with contrast-enhanced ultrasonography. Ultraschall Med 2008 29:506–514.
  • Faccioli N, D'Onofrio M, Malag`o R, Zamboni G, Falconi M, Capelli P, Mucelli RP. Resectable pancreatic adenocarcinoma: depiction of tumoral margins at contrast-enhanced ultrasonography. Pancreas 2008 37:265–268.
  • Recaldini C, Carrafiello G, Bertolotti E, Angeretti MG, Fugazzola C. Contrast-enhanced ultrasonograpic findings in pancreatic tumors. Int J Med Sci 2008 5:203–208.
  • Serra C, Menozzi G, Labate AM, Giangregorio F, Gionchetti P, Beltrami M, Robotti D, Fornari F, Cammarota T. Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn's disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent. Eur J Radiol 2007 62:114–121.
  • Migaleddu V, Scanu AM, Quaia E, Rocca PC, Dore MP, Scanu D, Azzali L, Virgilio G. Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn's disease. Gastroenterology 2009 137:43–52.
  • Quaia E, Migaleddu V, Baratella E, Pizzolato R, Rossi A, Grotto M, Cova MA. The diagnostic value of small bowel wall vascularity after sulfur hexafluoride-filled microbubble injection in patients with Crohn's disease. Correlation with the therapeutic effectiveness of specific anti-inflammatory treatment. Eur J Radiol 2009 69:438–444.
  • Nylund K, Hausken T, Gilja OH. Ultrasound and inflammatory bowel disease. Ultrasound Q 2010 26:3–15.
  • Dayton PA, Rychak JJ. Molecular ultrasound imaging using microbubble contrast agents. Frontiers Biosci 2007 12:5124–5142.
  • Postema M, Gilja OH. Ultrasound-directed drug delivery. Curr Pharm Biotechnol 2007 8:355–361.
  • Bao S, Thrall BD, Miller DL. Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med Biol 1997 23:953–959.
  • Miller DL, Bao S, Morris JE. Sonoporation of cultured cells in the rotating tube exposure system. Ultrasound Med Biol 1999 25:143–149.
  • Karshafian R, Samac S, Banerjee M, Bevan PD, Burns PN. Ultrasound-induced uptake of different size markers in mammalian cells. Proc IEEE Ultrason Symp 2005 1:13–16.
  • Schlicher RK, Radhakrishna H, Tolentino TP, Apkarian RP, Zarnitsyn V, Prausnitz MR. Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med Biol 2006 32:915– 924.
  • Song J, Chappell JC, Qi M, VanGieson EJ, Kaul S, Price RJ. Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle. J Am Coll Cardiol 2002 39:726–731.
  • Mehier-Humbert S, Bettinger T, Yan F, Guy RH. Plasma membrane poration induced by ultrasound exposure: implication for drug delivery. J Control Release 2005 104:213–222.
  • van Wamel A, Kooiman K, Harteveld M, Emmer M, ten Cate FJ, Versluis M, de Jong N. Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release 2006 112:149–155.
  • Prentice P, Cuschieri A, Dholakia K, Prausnitz M, Campbell P. Membrane disruption by optically controlled microbubble cavitation. Nature Phys 2005 1:107–110.
  • Postema M, Gilja OH. Jetting does not cause sonoporation. Biomed Tech (Biomed Eng) 2010 55:S19–S20.
  • Marmottant P, Hilgenfeldt S. Controlled vesicle deformation and lysis by single oscillating bubbles. Nature 2003 423:153–156.
  • Miller DL, Nyborg WL. Theoretical investigation of the response of gas-filled micropores and cavitation nuclei to ultrasound. J Acoust Soc Am 1983 73:1537–1544.
  • Miller DL, Song J. Lithotripter shock waves with cavitation nucleation agents produce tumor growth reduction and gene transfer in vivo. Ultrasound Med Biol 2002 28:1343–1348.
  • Tinkov S, Bekeredjian R, Winter G, Coester C. Microbubbles as ultrasound triggered drug carriers. J Pharm Sci 2009 98:1935–1961.
  • Klibanov AL. Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv Drug Delivery Rev 1999 37:139–157.
  • Porter TR, Xie F. Therapeutic ultrasound for gene delivery. Echocardiography 2001 18:349–353.
  • Shohet RV, Chen S, Zhou Y-T, Wang Z, Meidell RS, Unger RH, Grayburn PA. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000 101:2554–2556.
  • Christiansen JP, French BA, Klibanov AL, Kaul S, Lindner JR. Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med Biol 2003 29:1759–1767.
  • Frenkel PA, Chen S, Thai T, Shohet RV, Grayburn PA. DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med Biol 2002 28:817– 822.
  • Bloch SH, Wan M, Dayton PA, Ferrara KW. Optical observation of lipid- and polymer-shelled ultrasound microbubble contrast agents. Appl Phys Lett 2004 84:631–633.
  • Dayton P, Morgan K, Allietta M, Klibanov A, Brandenburger G, Ferrara K. Simultaneous optical and acoustical observations of contrast agents. Proc IEEE Ultrason Symp 1997 2:1583–1591.
  • Postema M, ten Cate FJ, Schmitz G, de Jong N, van Wamel A. Generation of a droplet inside a microbubble with the aid of an ultrasound contrast agent: first result. Lett Drug Des Discov 2007 4:74–77.
  • Miller DL, Dou C, Song J. DNA transfer and cell killing in epidermoid cells by diagnostic ultrasound activation of contrast agent gas bodies in vitro. Ultrasound Med Biol 2003 29:601–607.
  • Hallow DM, Mahajan AD, McCutchen TE, Prausnitz MR. Measurement and correlation of acoustic cavitation with cellular bioeffects. Ultrasound Med Biol 2006 32:1111–1122.
  • Feril Jr LB, Kondo T, Takaya K, Riesz P. Enhanced ultrasound-induced apoptosis and cell lysis by a hypotonic medium. Int J Radiat Biol 2004 80:165–175.
  • Watanabe A, Kawai K, Sato T, Nishimura H, Kawashima N, Takeuchi S. Apoptosis induction in cancer cells by ultrasound exposure. Jap J Appl Phys 2004 43:3245–3248.
  • Abdollahi A, Domhan S, Jenne JW, Hallaj M, Dell'Aqua G, Mueckenthaler M, Richter A, Martin H, Debus J, Ansorge W, Hynynen K, Huber PE. Apoptosis signals in lymphoblasts induced by focused ultrasound. FASEB J 2004 18:1413–1414.
  • Miller MW, Miller DL, Brayman AA. A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective. Ultrasound Med Biol 1996 22:1131–1154.
  • Bekeredjian R, Grayburn PA, Shohet RV. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol 2005 45:329–335.
  • ter Haar GR. High intensity focused ultrasound for the treatment of tumors. Echocardiography 2001 18:317–322.
  • Liu Y, Kon T, Li C, Zhong P. High intensity focused ultrasound-induced gene activation in sublethally injured tumor cells in vitro. J Acoust Soc Am 2005 118:3328–3336.
  • Tung Y-S, Liu H-L, Wu C-C, Ju K-C, Chen W-S, Lin W-L. Contrast-agent-enhanced ultrasound thermal ablation. Ultrasound Med Biol 2006 32:1103–1110.
  • Fujishiro S, Mitsumori M, Nishimura Y, Okuno Y, Nagata Y, Hiraoka M, Sano T, Marume T, Takayama N. Increased heating efficiency of hyperthermia using an ultrasound contrast agent: a phantom study. Int J Hyperthermia 1998 14:495–502.
  • Kaneko Y, Maruyama T, Takegami K, Watanabe T, Mitsui H, Hanajiri K, Nagawa H, Matsumoto Y. Use of microbubble agent to increase the effects of high intensity focused ultrasound on liver tissue. Eur Radiol 2005 15:1415–1420.
  • Tran BC, Seo J, Hall TL, Fowlkes JB, Cain CA. Microbubble-enhanced cavitation for noninvasive ultrasound surgery. IEEE Trans Ultrason Ferroelectr Freq Control 2003 50:1296–1304.
  • Eisenmenger W. The mechanisms of stone fragmentation in ESWL. Ultrasound Med Biol 2001 27:683–693.
  • Eisenmenger W, Du XX, Tang C, Zhao S, Wang Y, Rong F, Dai D, Guan M, Qi A. The first clinical results of "wide-focus and low-pressure" ESWL. Ultrasound Med Biol 2002 28:769–774.